These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 22449523)

  • 21. Neurotoxicity of isoniazid and its metabolites in cultures of mouse dorsal root ganglion neurons and hybrid neuronal cell line.
    Sanfeliu C; Wright JM; Kim SU
    Neurotoxicology; 1999 Dec; 20(6):935-44. PubMed ID: 10693974
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does CYP2E1 play a major role in the aggravation of isoniazid toxicity by rifampicin in human hepatocytes?
    Yue J; Peng R
    Br J Pharmacol; 2009 Jun; 157(3):331-3. PubMed ID: 19371336
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolomics describes previously unknown toxicity mechanisms of isoniazid and rifampicin.
    Combrink M; Loots DT; du Preez I
    Toxicol Lett; 2020 Apr; 322():104-110. PubMed ID: 31981687
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatoprotective potential of ethanolic extract of Ziziphus oenoplia (L.) Mill roots against antitubercular drugs induced hepatotoxicity in experimental models.
    Rao ChV; Rawat AK; Singh AP; Singh A; Verma N
    Asian Pac J Trop Med; 2012 Apr; 5(4):283-8. PubMed ID: 22449519
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lack of liver injury in Wistar rats treated with the combination of isoniazid and rifampicin.
    Metushi IG; Uetrecht J
    Mol Cell Biochem; 2014 Feb; 387(1-2):9-17. PubMed ID: 24150712
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatoprotective effects of Yulangsan polysaccharide against isoniazid and rifampicin-induced liver injury in mice.
    Dong Y; Huang J; Lin X; Zhang S; Jiao Y; Liang T; Chen Z; Huang R
    J Ethnopharmacol; 2014 Feb; 152(1):201-6. PubMed ID: 24412379
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of oxidative stress and nitric oxide in the protective effects of alpha-lipoic acid and aminoguanidine against isoniazid-rifampicin-induced hepatotoxicity in rats.
    Saad EI; El-Gowilly SM; Sherhaa MO; Bistawroos AE
    Food Chem Toxicol; 2010 Jul; 48(7):1869-75. PubMed ID: 20417245
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of oxygen free radicals in isoniazid-induced hepatotoxicity.
    Walubo A; Smith P; Folb PI
    Methods Find Exp Clin Pharmacol; 1998 Oct; 20(8):649-55. PubMed ID: 9922980
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Involvement of protoporphyrin IX accumulation in the pathogenesis of isoniazid/rifampicin-induced liver injury: the prevention of curcumin.
    He L; Guo Y; Deng Y; Li C; Zuo C; Peng W
    Xenobiotica; 2017 Feb; 47(2):154-163. PubMed ID: 28118809
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of chitosan supplementation on antitubercular drugs-induced hepatotoxicity in rats.
    Santhosh S; Sini TK; Anandan R; Mathew PT
    Toxicology; 2006 Feb; 219(1-3):53-9. PubMed ID: 16337069
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of rifampicin on pharmacokinetics of isoniazid and its metabolite acetylhydrazine in rats.
    Zhang RL; Wang ZY; Li D; Cheng WB
    Zhongguo Yao Li Xue Bao; 1992 Nov; 13(6):494-6. PubMed ID: 1302435
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatoprotective effect of tocopherol against isoniazid and rifampicin induced hepatotoxicity in albino rabbits.
    Tayal V; Kalra BS; Agarwal S; Khurana N; Gupta U
    Indian J Exp Biol; 2007 Dec; 45(12):1031-6. PubMed ID: 18254208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytoprotective effects of taurine against toxicity induced by isoniazid and hydrazine in isolated rat hepatocytes.
    Heidari R; Babaei H; Eghbal MA
    Arh Hig Rada Toksikol; 2013 Jun; 64(2):15-24. PubMed ID: 23819928
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatotoxicity mechanisms of isoniazid: A mini-review.
    Hassan HM; Guo HL; Yousef BA; Luyong Z; Zhenzhou J
    J Appl Toxicol; 2015 Dec; 35(12):1427-32. PubMed ID: 26095833
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Acute toxic action of combinations of antibiotics with isoniazid].
    Ziia AV; Sokolova GB; Lebedeva MN
    Antibiotiki; 1982; 27(7):535-9. PubMed ID: 7137978
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monoammonium glycyrrhizinate protects rifampicin- and isoniazid-induced hepatotoxicity via regulating the expression of transporter Mrp2, Ntcp, and Oatp1a4 in liver.
    Zhou L; Song Y; Zhao J; Qin H; Zhang G; Zhou Y; Wu X
    Pharm Biol; 2016; 54(6):931-7. PubMed ID: 26987268
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oxidative stress potentiated by diallylsulfide, a selective CYP2E1 inhibitor, in isoniazid toxic effect on rat primary hepatocytes.
    Zhai Q; Lu SR; Lin Y; Yang QL; Yu B
    Toxicol Lett; 2008 Dec; 183(1-3):95-8. PubMed ID: 18992798
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytochemical Evaluation of the Toxic Effects of Combined Antituberculosis Substances on Metabolic State of Blood Lymphocytes.
    Dolgushin MV
    Bull Exp Biol Med; 2020 Feb; 168(4):470-473. PubMed ID: 32146623
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hepatotoxic action of rifampicin and isonicotinic acid hydrazide].
    Kozma D; Mihalik P; Schaff Z; Lapis K
    Probl Tuberk; 1982 Jul; (7):68-72. PubMed ID: 7134213
    [No Abstract]   [Full Text] [Related]  

  • 40. The protective effects of ursodeoxycholic acid on isoniazid plus rifampicin induced liver injury in mice.
    Chen X; Xu J; Zhang C; Yu T; Wang H; Zhao M; Duan ZH; Zhang Y; Xu JM; Xu DX
    Eur J Pharmacol; 2011 May; 659(1):53-60. PubMed ID: 21419764
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.